Lung cancer diagnosis with quantitative DIC microscopy and support vector machine

We report the study of lung squamous cell carcinoma diagnosis using the TI-DIC microscopy and the scattering-phase theorem. The spatially resolved optical properties of tissue are computed from the 2D phase map via the scattering-phase theorem. The scattering coefficient, the reduced scattering coefficient, and the anisotropy factor are all found to increase with the grade of lung cancer. The retrieved optical parameters are shown to distinguish cancer cases from the normal cases with high accuracy. This label-free microscopic approach applicable to fresh tissues may be promising for in situ rapid cancer diagnosis. © (2017) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only

Real-time spatial frequency domain imaging by single snapshot multiple frequency demodulation technique

We have presented a novel Single Snapshot Multiple Frequency Demodulation (SSMD) method enabling single snapshot wide field imaging of optical properties of turbid media in the Spatial Frequency Domain. SSMD makes use of the orthogonality of harmonic functions and extracts the modulation transfer function (MTF) at multiple modulation frequencies and of arbitrary orientations and amplitudes simultaneously from a single structured-illuminated image at once. SSMD not only increases significantly the data acquisition speed and reduces motion artifacts but also exhibits excellent noise suppression in imaging as well. The performance of SSMD-SFDI is demonstrated with experiments on both tissue mimicking phantoms and in vivo for recovering optical properties. SSMD is ideal in the implementation of a real-time spatial frequency domain imaging platform, which will open up SFDI for vast applications in, for example, mapping the optical properties of a dynamic turbid medium or monitoring fast temporal evolutions. © (2017) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only

Single snapshot multiple frequency modulated imaging of subsurface optical properties of turbid media with structured light

We report a novel demodulation method that enables single snapshot wide field imaging of optical properties of turbid media in the Spatial Frequency Domain (SFD). This Single Snapshot Multiple frequency Demodulation (SSMD) method makes use of the orthogonality of harmonic functions to extract the modulation transfer function (MTF) at multiple modulation frequencies simultaneously from a single structured-illuminated image at once. The orientation, frequency, and amplitude of each modulation can be set arbitrarily subject to the limitation of the implementation device. We first validate and compare SSMD to the existing demodulation methods by numerical simulations. The performance of SSMD is then demonstrated with experiments on both tissue mimicking phantoms and in vivo for recovering optical properties by comparing to the standard three-phase demodulation approach. The results show that SSMD increases significantly the data acquisition speed and reduces motion artefacts. SSMD exhibits excellent noise suppression in imaging as well at the rate proportional to the square root of the number of pixels contained in its kernel. SSMD is ideal in the implementation of a real-time spatial frequency domain imaging platform and will open up SFDI for vast applications in imaging and monitoring dynamic turbid medium and processes

In vivo real-time imaging of cutaneous hemoglobin concentration, oxygen saturation, scattering properties, melanin content, and epidermal thickness with visible spatially modulated light

We present the real-time single snapshot multiple frequency demodulation - spatial frequency domain imaging (SSMD-SFDI) platform implemented with a visible digital mirror device that is capable of imaging and monitoring dynamic turbid medium and processes over a large field of view. One challenge in quantitative imaging of biological tissue such as the skin is the complex structure rendering techniques based on homogeneous medium models to fail. To address this difficulty we have also developed a novel method that maps the layered structure to a homogeneous medium for spatial frequency domain imaging. The varying penetration depth of spatially modulated light on its wavelength and modulation frequency is used to resolve the layered structure. The efficacy of the real-time SSMD-SFDI platform and this two-layer model is demonstrated by imaging forearms of 6 healthy subjects under the reactive hyperemia protocol. The results show that our approach not only successfully decouples light absorption by melanin from that by hemoglobin and yields accurate determination of cutaneous hemoglobin concentration and oxygen saturation, but also provides reliable estimation of the scattering properties, the melanin content and the epidermal thickness in real time. Potential applications of our system in imaging skin physiological and functional states, cancer screening, and microcirculation monitoring are discussed at the end. © 2017 Optical Society of Americ

DeCoST: A New Approach in Drug Repurposing From Control System Theory

In this paper, we propose DeCoST (Drug Repurposing from Control System Theory) framework to apply control system paradigm for drug repurposing purpose. Drug repurposing has become one of the most active areas in pharmacology since the last decade. Compared to traditional drug development, drug repurposing may provide more systematic and significantly less expensive approaches in discovering new treatments for complex diseases. Although drug repurposing techniques rapidly evolve from “one: disease-gene-drug” to “multi: gene, dru” and from “lazy guilt-by-association” to “systematic model-based pattern matching,” mathematical system and control paradigm has not been widely applied to model the system biology connectivity among drugs, genes, and diseases. In this paradigm, our DeCoST framework, which is among the earliest approaches in drug repurposing with control theory paradigm, applies biological and pharmaceutical knowledge to quantify rich connective data sources among drugs, genes, and diseases to construct disease-specific mathematical model. We use linear–quadratic regulator control technique to assess the therapeutic effect of a drug in disease-specific treatment. DeCoST framework could classify between FDA-approved drugs and rejected/withdrawn drug, which is the foundation to apply DeCoST in recommending potentially new treatment. Applying DeCoST in Breast Cancer and Bladder Cancer, we reprofiled 8 promising candidate drugs for Breast Cancer ER+ (Erbitux, Flutamide, etc.), 2 drugs for Breast Cancer ER- (Daunorubicin and Donepezil) and 10 drugs for Bladder Cancer repurposing (Zafirlukast, Tenofovir, etc.)

Exploration on undergraduate curriculum reform of hospital-oriented biomedical engineering major

AbstractThis paper focuses on improving the status quo ofundergraduate education of biomedical engineering students inChina. With consideration of the particular job requirement andneeds of hospitals for biomedical engineering professionals, weaddress a series of proposed hospital-oriented improvments onundergraduate curriculum reform, laboratory development andstudents training etc.. To simplify the description, WenzhouMedical College is taken as an example.3 Halama

Single snapshot multiple frequency modulated imaging of subsurface optical properties of turbid media with structured light

We report a novel demodulation method that enables single snapshot wide field imaging of optical properties of turbid media in the Spatial Frequency Domain (SFD). This Single Snapshot Multiple frequency Demodulation (SSMD) method makes use of the orthogonality of harmonic functions to extract the modulation transfer function (MTF) at multiple modulation frequencies simultaneously from a single structured-illuminated image at once. The orientation, frequency, and amplitude of each modulation can be set arbitrarily subject to the limitation of the implementation device. We first validate and compare SSMD to the existing demodulation methods by numerical simulations. The performance of SSMD is then demonstrated with experiments on both tissue mimicking phantoms and in vivo for recovering optical properties by comparing to the standard three-phase demodulation approach. The results show that SSMD increases significantly the data acquisition speed and reduces motion artefacts. SSMD exhibits excellent noise suppression in imaging as well at the rate proportional to the square root of the number of pixels contained in its kernel. SSMD is ideal in the implementation of a real-time spatial frequency domain imaging platform and will open up SFDI for vast applications in imaging and monitoring dynamic turbid medium and processes

Data_Sheet_1_DeCoST: A New Approach in Drug Repurposing From Control System Theory.DOCX

<p>In this paper, we propose DeCoST (Drug Repurposing from Control System Theory) framework to apply control system paradigm for drug repurposing purpose. Drug repurposing has become one of the most active areas in pharmacology since the last decade. Compared to traditional drug development, drug repurposing may provide more systematic and significantly less expensive approaches in discovering new treatments for complex diseases. Although drug repurposing techniques rapidly evolve from “one: disease-gene-drug” to “multi: gene, dru” and from “lazy guilt-by-association” to “systematic model-based pattern matching,” mathematical system and control paradigm has not been widely applied to model the system biology connectivity among drugs, genes, and diseases. In this paradigm, our DeCoST framework, which is among the earliest approaches in drug repurposing with control theory paradigm, applies biological and pharmaceutical knowledge to quantify rich connective data sources among drugs, genes, and diseases to construct disease-specific mathematical model. We use linear–quadratic regulator control technique to assess the therapeutic effect of a drug in disease-specific treatment. DeCoST framework could classify between FDA-approved drugs and rejected/withdrawn drug, which is the foundation to apply DeCoST in recommending potentially new treatment. Applying DeCoST in Breast Cancer and Bladder Cancer, we reprofiled 8 promising candidate drugs for Breast Cancer ER+ (Erbitux, Flutamide, etc.), 2 drugs for Breast Cancer ER- (Daunorubicin and Donepezil) and 10 drugs for Bladder Cancer repurposing (Zafirlukast, Tenofovir, etc.).</p